AGPAT2 Antikörper (C-Term)
Kurzübersicht für AGPAT2 Antikörper (C-Term) (ABIN205054)
Target
Alle AGPAT2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Human AGPAT2
-
Homologie
- Percent identity by BLAST analysis: Human (100%).
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human AGPAT2 (Q5VUD3, NP_001012745). Percent identity by BLAST analysis: Human, Gorilla (100%), Monkey (92%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: WB (5 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
Andere Bezeichnung
- AGPAT2
-
Hintergrund
-
Name/Gene ID: AGPAT2
Synonyms: AGPAT2, 1-AGPAT2, 1-AGPAT 2, 1-AGP acyltransferase 2, BSCL, BSCL1, LPAAB, LPAAT-beta -
Gen-ID
- 10555
-
NCBI Accession
- NP_001012745
-
UniProt
- O15120
Target
-